Kennedy Capital Management, Inc. Selecta Biosciences Inc Transaction History

Kennedy Capital Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 13, 2019	SELL	$1.47 - $3.06 $883,414 - $1.84 Million	-600,962 Closed	0 $0
Q4 2018 Feb 12, 2019	SELL	$2.66 - $15.93 $396,699 - $2.38 Million	-149,135 Reduced 19.88%	600,962 $1.6 Million
Q3 2018 Nov 14, 2018	BUY	$12.07 - $16.0 $2.45 Million - $3.25 Million	203,218 Added 37.16%	750,097 $11.7 Million
Q2 2018 Aug 14, 2018	BUY	$9.36 - $13.25 $4.27 Million - $6.05 Million	456,627 Added 505.95%	546,879 $7.25 Million
Q1 2018 May 14, 2018	SELL	$8.49 - $11.82 $69,813 - $97,195	-8,223 Reduced 8.35%	90,252 $920,000
Q4 2017 Feb 13, 2018	BUY	$8.97 - $23.38 $883,320 - $2.3 Million	98,475	98,475 $966,000

4.67M

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Kennedy Capital Management, Inc. with notifications on news.